Literature DB >> 27765000

How to treat a fulminant erysipelas and sepsis caused by Myroides odoratimimus: case report and literature review.

Philippe Willems1, Jan Muller2, Jan Verhaegen1, Veroniek Saegeman1, Stefanie Desmet1.   

Abstract

We report a case of a 77-year old male who developed a fulminant erysipelas and sepsis, caused by Myroides odoratimimus. Selecting the optimal antibiotic therapy for the treatment of infections with M. odoratimimus is challenging due to limited clinical experience with this micro-organism and its reported multidrug-resistance. Review of previous studies concerning in vitro antibacterial susceptibility and clinical experience with M. odoratimimus resulted in six case reports describing bacteremia, soft tissue and bone infections, pneumonia and urinary tract infections. In vitro susceptibility to aminoglycosides, fluoroquinolones and trimethoprim/sulfamethoxazole is variable. Treatment of M. odoratimimus infections should be based on antimicrobial susceptibility testing results. In a majority of the case reports, including the present one, treatment with fluoroquinolones proved to be a good therapeutic option.

Entities:  

Keywords:  Antimicrobial susceptibility testing; Erysipelas; Flavobacterium odoratimimus; Myroides odoratimimus; Sepsis

Mesh：

Substances：

Year:  2016        PMID： 27765000     DOI： 10.1080/17843286.2016.1245173

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN： 1784-3286            Impact factor:   1.264


  8 in total

1.  Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain.

Authors:  Arianna Pompilio; Giuseppe Galardi; Giovanni Gherardi; Fabio Verginelli; Cristina Geminiani; Argenia Paola Pilloni; Piergiorgio Catalanotti; Giovanni Di Bonaventura
Journal:  Folia Microbiol (Praha)       Date:  2017-09-27       Impact factor: 2.099

Review 2.  Myroides injenensis Bacteremia and Severe Cellulitis.

Authors:  Stephanie LaVergne; Thaidra Gaufin; Douglas Richman
Journal:  Open Forum Infect Dis       Date:  2019-06-17       Impact factor: 3.835

3.  Myroides bacteremia: A case report and concise review.

Authors:  Rudra Beharrysingh
Journal:  IDCases       Date:  2017-02-28

4.  Extensively drug-resistant Myroides odoratimimus - a case series of urinary tract infections in immunocompromised patients.

Authors:  Monica Licker; Teodora Sorescu; Maria Rus; Natalia Cirlea; Florin Horhat; Cristiana Jurescu; Mircea Botoca; Alin Cumpănaş; Romulus Timar; Delia Muntean
Journal:  Infect Drug Resist       Date:  2018-05-18       Impact factor: 4.003

5.  Myroides odoratimimus urinary tract infection in an immunocompromised patient: an emerging multidrug-resistant micro-organism.

Authors:  Giovanni Lorenzin; Giorgio Piccinelli; Lucrezia Carlassara; Francesco Scolari; Francesca Caccuri; Arnaldo Caruso; Maria Antonia De Francesco
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-06       Impact factor: 4.887

6.  Comparative genomic analysis of Myroides odoratimimus isolates.

Authors:  Shaohua Hu; Lin Cao; Yiyin Wu; Yajun Zhou; Tao Jiang; Liqiang Wang; Qiujing Wang; Desong Ming; Shicheng Chen; Mingxi Wang
Journal:  Microbiologyopen       Date:  2018-05-23       Impact factor: 3.139

7.  A Confirmed Catheter-Related Blood Stream Infection (CRBSI) in an Immunocompetent Patient Due to Myroides odoratimimus: Case Report and Literature Review.

Authors:  Yanfei Lu; Wenying Xia; Xiaohui Zhang; Fang Ni; Yaning Mei
Journal:  Infect Drug Resist       Date:  2020-01-10       Impact factor: 4.003

8.  Extensively Drug-Resistant Myroides odoratus in Critically Ill Patients: A Case Series and Literature Review.

Authors:  Melissa O'Neal; Caitlin E Labay; Jesse E Harris; William L Musick; Patricia L Cernoch; Kevin A Grimes; Jiejian Lin; Shivan Shah; Elizabeth Ramos-Salazar
Journal:  Case Rep Infect Dis       Date:  2022-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.